We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+11.21%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$518B
AUM Growth
+$18.2B
Cap. Flow
-$36B
Cap. Flow %
-6.94%
Top 10 Hldgs %
29.96%
Holding
15,912
New
1,749
Increased
6,361
Reduced
6,148
Closed
1,439

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.78B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$973M
3
DIS icon
Walt Disney
DIS
+$588M
4
LLY icon
Eli Lilly
LLY
+$569M
5
T icon
AT&T
T
+$529M

Sector Composition

Rank Sector Weight
1 Technology 3.4%
2 Healthcare 3.08%
3 Financials 2.41%
4 Consumer Discretionary 2.33%
5 Industrials 1.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AYX
15651
PUT
DELISTED
Alteryx Inc
AYX
-294,100
Closed -$13.9M
KRTX
15652
CALL
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
-47,000
Closed -$14.9M
KRTX
15653
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
-158,012
Closed -$50M
KRTX
15654
PUT
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
-49,400
Closed -$15.6M
SPLK
15655
CALL
DELISTED
Splunk Inc
SPLK
-686,200
Closed -$105M
SPLK
15656
DELISTED
Splunk Inc
SPLK
-513,964
Closed -$78.3M
SPLK
15657
PUT
DELISTED
Splunk Inc
SPLK
-396,500
Closed -$60.4M
BTTX
15658
CALL
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
-3,000
Closed -$585
BTTX
15659
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
-216,165
Closed -$42.2K
TGH
15660
CALL
DELISTED
Textainer Group Holdings limited
TGH
-2,200
Closed -$108K
TGH
15661
DELISTED
Textainer Group Holdings limited
TGH
-22,028
Closed -$1.08M
TGH
15662
PUT
DELISTED
Textainer Group Holdings limited
TGH
-10,500
Closed -$517K
ESEB
15663
DELISTED
Xtrackers J.P. Morgan ESG Emerging Markets Sovereign ETF
ESEB
-43,284
Closed -$735K
SOVO
15664
CALL
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
-900
Closed -$19.8K
SOVO
15665
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
-83,794
Closed -$1.85M
SOVO
15666
PUT
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
-1,600
Closed -$35.2K
SNCE
15667
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
-67,631
Closed -$361K
LBBBR
15668
DELISTED
Lakeshore Acquisition II Corp. Rights
LBBBR
-24,706
Closed -$3.95K
FAZE
15669
CALL
DELISTED
FaZe Holdings Inc. Common Stock
FAZE
-45,800
Closed -$8.24K
FAZE
15670
PUT
DELISTED
FaZe Holdings Inc. Common Stock
FAZE
-26,400
Closed -$4.75K
AMAM
15671
CALL
DELISTED
Ambrx Biopharma Inc
AMAM
-20,900
Closed -$298K
AMAM
15672
DELISTED
Ambrx Biopharma Inc
AMAM
-2,042,212
Closed -$29.1M
AMAM
15673
PUT
DELISTED
Ambrx Biopharma Inc
AMAM
-76,000
Closed -$1.08M
EXPR
15674
CALL
DELISTED
Express, Inc.
EXPR
-5,760
Closed -$48.2K
EXPR
15675
DELISTED
Express, Inc.
EXPR
-8,197
Closed -$68.6K

Similar funds

Citadel Advisors's Q1 2024 Portfolio in Review

As of Q1 2024, Citadel Advisors held 15,912 positions worth $518B, up 3.6% from $500B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Citadel Advisors withdrew a net $36B in Q1 2024, closing 1,439 positions and reducing 6,148 holdings. Its most notable exit was iShares National Muni Bond ETF, an estimated $183M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.4% of assets, down from 3.8% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Citadel Advisors opened a new position in TD Synnex worth $245M.

  • Citadel Advisors's largest Q1 2024 buy was TD Synnex: 2,162,840 shares worth $245M.
  • Citadel Advisors added most to Hess in Q1 2024, an estimated $1.28B increase.
  • Citadel Advisors's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $1.78B.
  • Citadel Advisors fully exited iShares National Muni Bond ETF in Q1 2024, selling an estimated $183M.
  • Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q1 2024.
  • Citadel Advisors opened 1,749 new positions and closed 1,439 in Q1 2024.
  • Citadel Advisors's portfolio value rose 3.6% quarter-over-quarter to $518B.

Based on Citadel Advisors's 13F filing for Q1 2024, filed 15 May 2024.